Bullfrog AI Holdings, Inc. BFRG

BFRG Company Overview

BullFrog AI Holdings, Inc. is a biotechnology and artificial intelligence company focused on improving drug development and clinical trial outcomes through machine learning and advanced analytics. The company operates at the intersection of the biopharmaceutical, healthcare technology, and data analytics industries, using proprietary AI-driven platforms to analyze complex biomedical and clinical datasets. Its primary business model centers on licensing and applying its analytical technology to pharmaceutical and biotechnology companies seeking to enhance drug discovery, patient stratification, and clinical development decision-making.

The company’s core technology platform was derived from research conducted at the Johns Hopkins University Applied Physics Laboratory, which contributed to BullFrog AI’s positioning in AI-enabled precision medicine and drug development analytics. BullFrog AI has evolved from a data analytics-focused biotechnology company into a publicly traded organization emphasizing AI-assisted therapeutic development and biomarker discovery. Public filings and investor materials indicate that the company seeks to differentiate itself through explainable AI models designed to identify hidden relationships in clinical and genomic datasets that may improve the probability of regulatory and commercial success for therapeutics.